C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/63 (2006.01) A61K 48/00 (2006.01) C12N 15/11 (2006.01) C12N 15/12 (2006.01)
Patent
CA 2739464
Oligonucleotide compounds modulate expression and/or function of an apolipoprotein (ApoA1) polynucleotides and encoded products thereof. Methods for treating diseases associated with apolipoprotein- A1 (ApoA1) comprise administering one or more Oligonucleotide compounds designed to inhibit the Apo-A1 natural antisense transcript to patients.
L'invention concerne des composés d'oligonucléotides qui modulent l'expression et/ou la fonction de polynucléotides d'une apolipoprotéine (ApoA1) et des produits codés de ceux-ci; des méthodes de traitement de maladies liées à l'apolipoprotéine Al (ApoA1), qui comprennent l'administration à des patients d'un ou de plusieurs composés d'oligonucléotides conçus pour inhiber le produit de la transcription de l'ApoA1 antisens naturel.
Collard Joseph
Khorkova Olga
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Opko Curna Llc
LandOfFree
Treatment of apolipoprotein-a1 related diseases by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of apolipoprotein-a1 related diseases by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of apolipoprotein-a1 related diseases by... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1504469